Jasbir Seehra

Person

Lexington, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Activin receptor type IIA variants and methods of use thereof
- Patent number 12,364,737
- Issue date Jul 22, 2025
- Keros Therapeutics, Inc.
- Jasbir S. Seehra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activin receptor type IIa variants and methods of use thereof
- Patent number 12,350,313
- Issue date Jul 8, 2025
- Keros Therapeutics, Inc.
- Jasbir S. Seehra
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
ALK2 antibodies and methods of use thereof
- Patent number 12,331,124
- Issue date Jun 17, 2025
- Keros Therapeutics, Inc.
- Jasbir S. Seehra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activin receptor type IIB variants and methods of use thereof
- Patent number 12,269,858
- Issue date Apr 8, 2025
- Keros Therapeutics, Inc.
- Jasbir S. Seehra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ALK1 receptor and ligand antagonists and uses thereof
- Patent number 12,144,860
- Issue date Nov 19, 2024
- Acceleron Pharma Inc.
- Asya Grinberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
GDNF fusion polypeptides and methods of use thereof
- Patent number 11,912,750
- Issue date Feb 27, 2024
- Keros Therapeutics, Inc.
- Jasbir S. Seehra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activin receptor type IIB variants and methods of use thereof
- Patent number 11,884,715
- Issue date Jan 30, 2024
- Keros Therapeutics, Inc.
- Jasbir S. Seehra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid molecules encoding activin receptor type IIA variants
- Patent number 11,717,558
- Issue date Aug 8, 2023
- Keros Therapeutics, Inc.
- Jasbir S. Seehra
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activin receptor type IIa variants and methods of use thereof
- Patent number 11,484,573
- Issue date Nov 1, 2022
- Keros Therapeutics, Inc.
- Jennifer Lachey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating anemia in a subject in need thereof
- Patent number 11,168,311
- Issue date Nov 9, 2021
- Acceleron Pharma Inc.
- Jasbir Seehra
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for treating anemia in a subject in need thereof
- Patent number 11,162,085
- Issue date Nov 2, 2021
- Acceleron Pharma Inc.
- Jasbir Seehra
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for treating anemia in a subject in need thereof
- Patent number 11,155,791
- Issue date Oct 26, 2021
- Acceleron Pharma Inc.
- Jasbir Seehra
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for promoting bone growth using activin-actriia antagonists
- Patent number 11,129,873
- Issue date Sep 28, 2021
- Acceleron Pharma Inc.
- John Knopf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activin receptor type IIa variants and methods of use thereof
- Patent number 11,090,361
- Issue date Aug 17, 2021
- Keros Therapeutics, Inc.
- Jasbir S. Seehra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for reducing serum lipids
- Patent number 11,066,654
- Issue date Jul 20, 2021
- Acceleron Pharma Inc.
- Jasbir Seehra
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for treating anemia in a subject in need thereof
- Patent number 11,028,375
- Issue date Jun 8, 2021
- Acceleron Pharma Inc.
- Jasbir Seehra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating anemia in a subject in need thereof
- Patent number 11,028,374
- Issue date Jun 8, 2021
- Acceleron Pharma Inc.
- Jasbir Seehra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activin receptor type IIA variants and methods of use thereof
- Patent number 11,013,785
- Issue date May 25, 2021
- Keros Therapeutics, Inc.
- Jasbir S. Seehra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of increasing sarcolemmal utrophin
- Patent number 10,968,262
- Issue date Apr 6, 2021
- Acceleron Pharma Inc.
- Jasbir Seehra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for screening compounds for increasing thermogenic adipocytes
- Patent number 10,968,282
- Issue date Apr 6, 2021
- Acceleron Pharma Inc.
- John Knopf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combined use of GDF traps and erythropoietin receptor activators to...
- Patent number 10,889,626
- Issue date Jan 12, 2021
- Acceleron Pharma Inc.
- Jasbir Seehra
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combined use of GDF traps and erythropoietin receptor activators to...
- Patent number 10,829,533
- Issue date Nov 10, 2020
- Acceleron Pharma Inc.
- Jasbir Seehra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combined use of gdf traps and erythropoietin receptor activators to...
- Patent number 10,829,532
- Issue date Nov 10, 2020
- Acceleron Pharma Inc.
- Jasbir Seehra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combined use of GDF traps and erythropoietin receptor activators to...
- Patent number 10,689,427
- Issue date Jun 23, 2020
- Acceleron Pharma Inc.
- Jasbir Seehra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of identifying ActRIIB variants
- Patent number 10,377,996
- Issue date Aug 13, 2019
- Acceleron Pharma Inc.
- Jasbir Seehra
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for producing an ActRIIB-Fc fusion polypeptide
- Patent number 10,358,633
- Issue date Jul 23, 2019
- Acceleron Pharma Inc.
- Jasbir Seehra
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Variants derived from ActRIIB and uses therefor
- Patent number 10,259,861
- Issue date Apr 16, 2019
- Acceleron Pharma Inc.
- John Knopf
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of promoting bone growth by an anti-actriia antibody
- Patent number 10,239,940
- Issue date Mar 26, 2019
- Acceleron Pharma Inc.
- John Knopf
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for treating refractory anemia with ringed sideroblasts
- Patent number 10,131,700
- Issue date Nov 20, 2018
- Acceleron Pharma Inc.
- Jasbir Seehra
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antagonists of activin-ActRIIa and uses for increasing red blood ce...
- Patent number 10,093,707
- Issue date Oct 9, 2018
- Acceleron Pharma Inc.
- Matthew L. Sherman
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ACTIVIN RECEPTOR TYPE IIB VARIANTS AND METHODS OF USE THEREOF
- Publication number 20250206799
- Publication date Jun 26, 2025
- Keros Therapeutics, Inc.
- Jasbir S. SEEHRA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF ADMINISTERING AN ACTIVIN RECEPTOR TYPE IIB VARIANT
- Publication number 20250188148
- Publication date Jun 12, 2025
- Keros Therapeutics, Inc.
- Jasbir S. SEEHRA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USING ALK2 INHIBITORS
- Publication number 20250034148
- Publication date Jan 30, 2025
- Keros Therapeutics, Inc.
- Jasbir S. SEEHRA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR PROMOTING BONE GROWTH USING ACTIVIN-ACTRIIA ANTAGONISTS
- Publication number 20240358793
- Publication date Oct 31, 2024
- Acceleron Pharma Inc.
- John Knopf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USING ACTIVIN RECEPTOR TYPE II SIGNALING INHIBITORS
- Publication number 20240252631
- Publication date Aug 1, 2024
- Keros Therapeutics, Inc.
- Jasbir S. SEEHRA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVIN RECEPTOR TYPE II CHIMERAS AND METHODS OF USE THEREOF
- Publication number 20240228583
- Publication date Jul 11, 2024
- Keros Therapeutics, Inc.
- Jasbir S. SEEHRA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF USING ACTIVIN RECEPTOR TYPE II SIGNALING INHIBITORS
- Publication number 20240218061
- Publication date Jul 4, 2024
- Keros Therapeutics, Inc.
- Jasbir S. SEEHRA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GDNF FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20240209048
- Publication date Jun 27, 2024
- Keros Therapeutics, Inc.
- Jasbir S. SEEHRA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ACTIVIN RECEPTOR TYPE IIB VARIANTS AND METHODS OF USE THEREOF
- Publication number 20240141012
- Publication date May 2, 2024
- Keros Therapeutics, Inc.
- Jasbir S. SEEHRA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVIN RECEPTOR TYPE IIA VARIANTS AND METHODS OF USE THEREOF
- Publication number 20240050528
- Publication date Feb 15, 2024
- Keros Therapeutics, Inc.
- Jasbir S. SEEHRA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF TREATING IRON OVERLOAD
- Publication number 20230406956
- Publication date Dec 21, 2023
- Keros Therapeutics, Inc.
- Jasbir S. SEEHRA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING CARDIOVASCULAR-RELATED DISEASE
- Publication number 20230398118
- Publication date Dec 14, 2023
- Keros Therapeutics, Inc.
- Jasbir S. SEEHRA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING LYMPHOPENIA
- Publication number 20230372390
- Publication date Nov 23, 2023
- Keros Therapeutics, Inc.
- Jasbir S. SEEHRA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USING ACTIVIN RECEPTOR TYPE II VARIANTS
- Publication number 20230348565
- Publication date Nov 2, 2023
- Keros Therapeutics, Inc.
- Jasbir S. SEEHRA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USING ACTIVIN RECEPTOR TYPE IIA VARIANTS
- Publication number 20230265162
- Publication date Aug 24, 2023
- Keros Therapeutics, Inc.
- Jasbir S. SEEHRA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USING ACTIVIN RECEPTOR TYPE IIB VARIANTS
- Publication number 20230087128
- Publication date Mar 23, 2023
- Keros Therapeutics, Inc.
- Jasbir S. SEEHRA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ACTIVIN RECEPTOR TYPE II CHIMERAS AND METHODS OF USE THEREOF
- Publication number 20230079602
- Publication date Mar 16, 2023
- Keros Therapeutics, Inc.
- Jasbir S. SEEHRA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF USING ALK2 INHIBITORS
- Publication number 20220401445
- Publication date Dec 22, 2022
- Keros Therapeutics, Inc.
- Jasbir S. SEEHRA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALK1 RECEPTOR AND LIGAND ANTAGONISTS AND USES THEREOF
- Publication number 20220296708
- Publication date Sep 22, 2022
- Acceleron Pharma Inc.
- Asya Grinberg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VARIANTS DERIVED FROM ACTRIIB AND USES THEREFOR
- Publication number 20220281951
- Publication date Sep 8, 2022
- Acceleron Pharma Inc.
- John Knopf
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR PROMOTING BONE GROWTH USING ACTIVIN-ACTRIIA ANTAGONISTS
- Publication number 20220211806
- Publication date Jul 7, 2022
- Acceleron Pharma Inc.
- John Knopf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONISTS OF ACTIVIN-ACTRIIA AND USES FOR INCREASING RED BLOOD CE...
- Publication number 20220204576
- Publication date Jun 30, 2022
- Acceleron Pharma Inc.
- Matthew L. Sherman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRUNCATED ACTRIIB-FC FUSION PROTEINS
- Publication number 20220169996
- Publication date Jun 2, 2022
- Acceleron Pharma Inc.
- Jasbir Seehra
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BMP-ALK3 ANTAGONISTS AND USES FOR PROMOTING BONE GROWTH
- Publication number 20220127330
- Publication date Apr 28, 2022
- Acceleron Pharma Inc.
- Jasbir Seehra
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ISOLATED GDF TRAP POLYPEPTIDE
- Publication number 20220098559
- Publication date Mar 31, 2022
- Acceleron Pharma Inc.
- Jasbir Seehra
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ACTRIIB PROTEINS AND VARIANTS AND USES THEREFORE RELATING TO UTROPH...
- Publication number 20220041670
- Publication date Feb 10, 2022
- Acceleron Pharma Inc.
- Jasbir Seehra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND PERICYTE C...
- Publication number 20220017600
- Publication date Jan 20, 2022
- Acceleron Pharma Inc.
- Asya Grinberg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR INCREASING THERMOGENIC ADIPOCYTES
- Publication number 20220017639
- Publication date Jan 20, 2022
- Acceleron Pharma Inc.
- John Knopf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND PERICYTE C...
- Publication number 20210388104
- Publication date Dec 16, 2021
- Ludwig Institute for Cancer Research Ltd.
- Asya Grinberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONISTS OF ACTIVIN-ACTRIIA AND USES FOR INCREASING RED BLOOD CE...
- Publication number 20210355181
- Publication date Nov 18, 2021
- Acceleron Pharma Inc.
- Matthew L. Sherman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Jasbir Seehra

Person

Patents Grantslast 30 patents

Activin receptor type IIA variants and methods of use thereof

Activin receptor type IIa variants and methods of use thereof

ALK2 antibodies and methods of use thereof

Activin receptor type IIB variants and methods of use thereof

ALK1 receptor and ligand antagonists and uses thereof

GDNF fusion polypeptides and methods of use thereof

Activin receptor type IIB variants and methods of use thereof

Nucleic acid molecules encoding activin receptor type IIA variants

Activin receptor type IIa variants and methods of use thereof

Methods for treating anemia in a subject in need thereof

Methods for treating anemia in a subject in need thereof

Methods for treating anemia in a subject in need thereof

Method for promoting bone growth using activin-actriia antagonists

Activin receptor type IIa variants and methods of use thereof

Methods and compositions for reducing serum lipids

Methods for treating anemia in a subject in need thereof

Methods for treating anemia in a subject in need thereof

Activin receptor type IIA variants and methods of use thereof

Methods of increasing sarcolemmal utrophin

Methods for screening compounds for increasing thermogenic adipocytes

Combined use of GDF traps and erythropoietin receptor activators to...

Combined use of GDF traps and erythropoietin receptor activators to...

Combined use of gdf traps and erythropoietin receptor activators to...

Combined use of GDF traps and erythropoietin receptor activators to...

Methods of identifying ActRIIB variants

Method for producing an ActRIIB-Fc fusion polypeptide

Variants derived from ActRIIB and uses therefor

Method of promoting bone growth by an anti-actriia antibody

Methods for treating refractory anemia with ringed sideroblasts

Antagonists of activin-ActRIIa and uses for increasing red blood ce...

Patents Applicationslast 30 patents

ACTIVIN RECEPTOR TYPE IIB VARIANTS AND METHODS OF USE THEREOF

METHODS OF ADMINISTERING AN ACTIVIN RECEPTOR TYPE IIB VARIANT

METHODS OF USING ALK2 INHIBITORS

METHOD FOR PROMOTING BONE GROWTH USING ACTIVIN-ACTRIIA ANTAGONISTS

METHODS OF USING ACTIVIN RECEPTOR TYPE II SIGNALING INHIBITORS

ACTIVIN RECEPTOR TYPE II CHIMERAS AND METHODS OF USE THEREOF

METHODS OF USING ACTIVIN RECEPTOR TYPE II SIGNALING INHIBITORS

GDNF FUSION POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVIN RECEPTOR TYPE IIB VARIANTS AND METHODS OF USE THEREOF

ACTIVIN RECEPTOR TYPE IIA VARIANTS AND METHODS OF USE THEREOF

METHODS OF TREATING IRON OVERLOAD

METHODS OF TREATING CARDIOVASCULAR-RELATED DISEASE

METHODS OF TREATING LYMPHOPENIA

METHODS OF USING ACTIVIN RECEPTOR TYPE II VARIANTS

METHODS OF USING ACTIVIN RECEPTOR TYPE IIA VARIANTS

METHODS OF USING ACTIVIN RECEPTOR TYPE IIB VARIANTS

ACTIVIN RECEPTOR TYPE II CHIMERAS AND METHODS OF USE THEREOF

METHODS OF USING ALK2 INHIBITORS

ALK1 RECEPTOR AND LIGAND ANTAGONISTS AND USES THEREOF

VARIANTS DERIVED FROM ACTRIIB AND USES THEREFOR

METHOD FOR PROMOTING BONE GROWTH USING ACTIVIN-ACTRIIA ANTAGONISTS

ANTAGONISTS OF ACTIVIN-ACTRIIA AND USES FOR INCREASING RED BLOOD CE...

TRUNCATED ACTRIIB-FC FUSION PROTEINS

BMP-ALK3 ANTAGONISTS AND USES FOR PROMOTING BONE GROWTH

ISOLATED GDF TRAP POLYPEPTIDE

ACTRIIB PROTEINS AND VARIANTS AND USES THEREFORE RELATING TO UTROPH...

METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND PERICYTE C...

METHODS FOR INCREASING THERMOGENIC ADIPOCYTES

METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND PERICYTE C...

ANTAGONISTS OF ACTIVIN-ACTRIIA AND USES FOR INCREASING RED BLOOD CE...